Journal of endocrinological investigation
-
J. Endocrinol. Invest. · Jul 2013
Randomized Controlled TrialEfficacy and safety of DT56a compared to hormone therapy in Greek post-menopausal women.
Hormone therapy (HT) is the treatment of choice for the alleviation of menopausal symptoms; concerns, however, about its concomitant long-term health risks have limited its use. DT56a is a unique enzymatic isolate of soybeans. The purpose of our study was to evaluate the efficacy and safety of DT56a, compared to HT, in symptomatic post-menopausal women. ⋯ DT56a decreased menopausal symptoms significantly and in the same degree as HT.